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or several decades, scientists have gathered evidence suggesting that young children are more
sensitive to the cancer-causing effects of some chemicals than adults. Now the U.S.
Environmental Protection Agency (EPA) has taken the unprecedented step of incorporating
that information into the methods it uses to assess risks posed by carcinogens. The agency is urging
scientists to assume, when chemical-specific data are missing, that children under age 2 are 10 times
more vulnerable to mutagenic carcinogens than adults, and that children aged 2–15 are 3 times
more vulnerable. These additional “adjustment factors,” when applied in risk assessments, could
tighten regulatory standards for some chemical products, thereby reducing the potential for child-
hood exposures.
The new recommended approaches are contained in the EPA’s draft Supplemental Guidance for
Assessing Cancer Susceptibility from Early-Life Exposure to Carcinogens. “The supplement,” as it is
routinely called, accompanies the agency’s most recent draft guidelines for cancer risk assessment,
which are expected to be finalized early in 2004. Scientists from across the agency use these guide-
lines, which were last revised in 1999, as a handbook for current EPA methods on assessing cancer
risks from environmental chemicals. 
The draft supplement—a first of its kind at the EPA—was developed in response to a recom-
mendation from the National Research Council and the EPA Science Advisory Board (SAB). “The
supplement represents a significant departure from existing EPA approaches because it calls for an
explicit assessment of children’s risk,” says William Wood, executive director of the EPA Risk
Assessment Forum. 
Wood says the supplement offers quantitative approaches based on a review of the currently
available data that compare early life stage responses—including fetal responses—to those of adults.
For its review, the EPA analyzed 23 peer-reviewed studies, extending back 50 years, of cancer inci-
dence following exposure to mutagens, nonmutagens, and radionuclides. 
The risk from childhood exposures to environmental chemicals is thought to be heightened for two
reasons. First, children’s behaviors make them prone to high exposures: they crawl on the ground, they
put their fingers in their mouths, and they inhale more air per unit body weight than adults. Second,
children’s developing organ systems can be uniquely vulnerable to chemically induced changes. 
The supplement addresses the latter situation. Limited animal data suggest that mutagenic car-
cinogens—which cause cancer by damaging DNA—can be particularly dangerous to children. Cells
divide more frequently during development, which provides less time for DNA to repair itself after
chemical attack. Some embryonic cells, such as brain cells, lack DNA-repair enzymes altogether. 
A Focus on Mutagenic Chemicals
According to Wood, the supplement directs EPA scientists to use the new adjustment factors only
when assessing mutagenic carcinogens. In other words, the factors are applied when a carcinogenic
mode of action is known to be mutagenic and when there are no chemical-specific studies in young
animals. Applying the factors represents a conservative approach that magnifies a carcinogen’s calcu-
lated potency among the targeted age groups. According to Wood, use of these adjustment factors is
justified by evidence showing that some mutagens (for instance, vinyl chloride and radionuclides that
interact with DNA) pose more of a cancer threat during early life stages than during adulthood. But even as the guidelines explicitly
assume heightened cancer risk from child-
hood exposures, they also acknowledge
that—for some carcinogens—the risks from
childhood and adult exposures may be simi-
lar. Furthermore, the guidelines emphasize
that nonmutagenic carcinogens may exhibit
dose “thresholds” below which cancer risks
among all humans are insignificant. This
represents a continuation of the agency’s
efforts, first expressed in draft revisions to
the 1996 version of the guidelines, to move
away from the assumption of linearity to a
more method-specific framework for
dose–response assessment. 
Says Wood, “The main thrust of the
guidelines is that you should work your way
through the data first. Based on that review,
you should then determine if you have
enough information to understand how a
chemical induces cancer and the resulting
likelihood for early life stage sensitivity.”
Such an understanding, he says, would aid
scientists in evaluating the need to fall back
on default assumptions. 
According to the guidelines, if data show
convincing evidence of a nonmutagenic
mode of action in young animals, then alter-
native approaches that depart from assump-
tions of dose linearity—that is, that risk is
proportional to dose—are warranted. These
alternative methods implicitly assume the
existence of a safe, low-dose exposure level
below which risk of cancer is unlikely. 
According to the draft guidelines, once
carcinogenic potency (or dose response) has
been evaluated, a chemical should be classi-
fied according to the following proposed
hazard descriptors: “carcinogenic to
humans,” “likely to be carcinogenic to
humans,” “suggestive evidence of carcino-
genic potential,” “inadequate information to
assess carcinogenic potential,” and “not like-
ly to be carcinogenic to humans.”
A Question of Thresholds
Wood agrees that, as the guidelines indicate,
the evidence on thresholds justifies nonlin-
ear methods to assess risks from nonmuta-
genic carcinogens for both children and
adults when sufficient mode-of-action data
are available. However, stakeholder opin-
ions on this point are far from unanimous. 
Environmental groups suggest that toxi-
cologists may not know enough about the
range of mechanistic possibilities to set
standards based on nonlinear assumptions.
“How do you know when you have suffi-
cient evidence to say a carcinogen has a
threshold?” asks Jennifer Sass, a senior sci-
entist with the Natural Resources Defense
Council. “Scientists may focus dispropor-
tionately on one mode of action and ignore
others that may be relevant to humans.” 
The guidelines recognize this problem,
and stipulate that multiple modes of action
should be considered to avoid this possibili-
ty, Sass says. But she is concerned that the
guidelines don’t provide enough guidance
on how multiple modes of action should be
evaluated. 
Wood counters that EPA scientists don’t
yet know enough about nonmutagens to
develop generic guidance on how to address
them. A case-by-case approach to these
chemicals is more suitable, he says.
“Stakeholders always want guidelines to be
more specific,” Wood says. “But these docu-
ments [are designed to stay] in place for
about a decade. By being overly specific and
not anticipating the evolution of the science,
you run the risk that the guidelines will
quickly go out of date.” 
SAB Review
Currently, the supplement is being reviewed
by the EPA SAB, a multistakeholder group
of experts that provides input on agency
activities. This review is still ongoing, and
neither SAB members nor EPA staff will dis-
cuss how the comments are being addressed
until deliberations are finished and a final
version is made available to the public (this
is expected by spring 2004). On 5 August
2003, the latest draft of the SAB comments
were published on the EPA website. Based
on that draft, it appears that the SAB agreed
that human fetuses and children are unique-
ly sensitive to carcinogens and applauded the
EPA’s efforts to consider children as a dis-
tinct subset of the population. 
However, contrary to the approach out-
lined in the supplement, the SAB recom-
mends that the EPA extend the application
of default adjustment factors to include
nonmutagenic carcinogens when modes of
action are unknown. George Lucier, former
director of the NIEHS Environmental
Toxicology Program, who cochaired a
stakeholder group involved in the early
stages of drafting the guidelines, says there
is evidence to suggest that children can be
more sensitive to nonmutagenic carcino-
gens than adults. 
He cites the example of transplacental
exposure to diethylstilbestrol, a synthetic
hormone, which was shown to induce vagi-
nal adenocarcinomas in girls during their
teenage years by nonmutagenic hormonal
disruption pathways. Adult women exhibit
much less sensitivity to this chemical, he
adds. Moreover, adult cancers do not
include the vaginal variety observed in chil-
dren. “The key point to make,” he says, “is
that children can be at higher risk even for
threshold carcinogens”—that is, those that
exert cancer-causing effects only when doses
exceed an experimentally defined minimum. 
Some additional SAB criticisms were
noted, among them a suggestion that EPA
scientists strengthen the evidence for early
life stage sensitivity with a broader search
of the literature. Furthermore, the SAB
recommended that EPA scientists add a
third age grouping (9–15 years) that would
recognize puberty’s potentially important
vulnerabilities, such as increased hormonal
activity.
The EPA is also considering public
comments provided by numerous stake-
holder interests. Among them are compa-
nies that could lose economically if the
guidelines were to pass in their present
form. Lucier says the use of child-specific
adjustment factors could impact markets
for some chemical products, for example by
changing the amount of certain classes of
pesticides that can be used in agriculture.
Adjustment factors could also influence
cleanup requirements for carcinogens at
hazardous waste sites, thereby driving up
the costs of remediation. 
One group that represents agrochemical
companies, in addition to other biotechnol-
ogy interests, is CropLife America, a trade
association based in Washington, D.C.
Angelina Duggan, director of science policy
at CropLife America, says industry wel-
comes the EPA’s ongoing effort to move
away from default assumptions. Her specif-
ic recommendation is that the EPA expand
its hazard descriptors to include a category
for chemicals that are “not carcinogenic to
humans.” Says Duggan, “If the mode of
action tells you that’s the case, then you
should clearly state that.”
Lucier says the new guidelines will put
the onus on industry to demonstrate that
fetuses and children are not, in fact, more
sensitive to chemical products than adults.
Most of the toxicology data generated today
derive from two-year bioassays in adult
rodents, he says. If companies want to avoid
the new adjustment factors, he says, they
will have to conduct full-lifetime exposure
studies or convincing mechanistic studies
that account for early life stage sensitivities. 
According to Wood, the agency will
continue to update its methods as new
information becomes available. He empha-
sizes that the guidelines embody a “living
document” designed to accommodate new
scientific discoveries. “[Cancer risk assess-
ment] is an evolving area,” he says.
“Millions of dollars are spent researching
modes of action for individual chemicals,
and I think we’re much farther along in our
mechanistic understandings. These guide-
lines provide us the ability to take that
information into effect.” 
Charles W. Schmidt
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